|
| ADR Term |
ADReCS ID |
ADR Frequency (FAERS)
|
ADR Severity Grade (FAERS)
|
ADR Severity Grade (CTCAE)
|
| Respiratory symptom | 22.12.02.013 | 0.000400% | | Not Available |
| Invasive breast carcinoma | 21.05.01.013; 16.10.01.005 | 0.000800% | | Not Available |
| Anal incontinence | 17.05.01.021; 07.01.06.029 | 0.012402% | | |
| Frustration tolerance decreased | 19.04.02.016 | 0.005641% | | Not Available |
| Ureterolithiasis | 20.04.03.003 | 0.000600% | | Not Available |
| Somatic symptom disorder | 19.24.01.006 | 0.000880% | | Not Available |
| Abnormal loss of weight | 14.03.02.019 | 0.002240% | | Not Available |
| Adenocarcinoma of colon | 16.13.01.010; 07.21.01.008 | 0.001000% | | Not Available |
| Adenocarcinoma of the cervix | 21.06.02.005; 16.12.01.003 | 0.001000% | | Not Available |
| Adjustment disorder with depressed mood | 19.23.01.002 | 0.000400% | | Not Available |
| Agraphia | 19.21.01.007; 17.02.03.013 | 0.002560% | | Not Available |
| Alopecia universalis | 23.02.02.010 | 0.000400% | | Not Available |
| Bladder transitional cell carcinoma | 16.08.01.002; 20.03.04.003 | 0.000600% | | Not Available |
| Breast cancer recurrent | 21.05.01.017; 16.10.01.009 | 0.000600% | | Not Available |
| Breast cancer stage I | 21.05.01.018; 16.10.01.010 | 0.000800% | | Not Available |
| Breast cancer stage II | 21.05.01.019; 16.10.01.011 | 0.000400% | | Not Available |
| Central nervous system lymphoma | 18.04.04.013; 17.02.10.028; 16.20.01.005; 01.12.01.005 | 0.000400% | | Not Available |
| Cervical spinal stenosis | 17.10.02.006; 15.10.04.006 | 0.000800% | | Not Available |
| Cholangitis acute | 09.02.01.006 | 0.000400% | | Not Available |
| Chronic gastritis | 11.07.01.016; 10.04.04.011; 07.08.02.005 | 0.000800% | | Not Available |
| Eosinophilic fasciitis | 15.06.01.013; 10.04.02.008; 01.02.04.010 | 0.001080% | | Not Available |
| Faeces pale | 07.01.03.005 | 0.003121% | | Not Available |
| Gait spastic | 17.01.04.018; 08.01.02.009 | 0.002720% | | Not Available |
| Gastroenteritis eosinophilic | 07.08.03.014; 01.02.04.018 | 0.001360% | | Not Available |
| Large for dates baby | 18.04.02.004 | 0.000400% | | Not Available |
| Lung adenocarcinoma | 22.08.01.007; 16.19.01.002 | 0.000600% | | Not Available |
| Lung carcinoma cell type unspecified stage IV | 22.08.01.019; 16.19.02.006 | 0.000400% | | Not Available |
| Malignant melanoma in situ | 16.03.01.004; 23.08.01.004 | 0.001000% | | Not Available |
| Malignant melanoma stage I | 23.08.01.005; 16.03.01.005 | 0.001200% | | Not Available |
| Malignant melanoma stage III | 23.08.01.007; 16.03.01.007 | 0.000400% | | Not Available |
